Jamaica vs Morocco: HIV/AIDS deaths averted by antiretroviral therapy
Jamaica
1,044 deaths
in 2022
Morocco
1,213 deaths
in 2024
Jamaica rank
72nd
Morocco rank
70th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Jamaica
- Morocco
How they compare
Morocco currently reports 1,213 deaths against 1,044 deaths in Jamaica, a difference of 169 deaths.
That makes Morocco's figure about 1.2 times Jamaica's.
The two have swapped places 4 times across 33 shared years of data; in 1990 it was Morocco ahead.
Jamaica ranks 72nd and Morocco ranks 70th of 157 countries.
Jamaica has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Jamaica | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 310 deaths | 183.06 deaths | 126.94 deaths | Jamaica |
| 2010s | 1,136 deaths | 725.97 deaths | 410.53 deaths | Jamaica |
| 2020s | 1,127 deaths | 1,032 deaths | 95.08 deaths | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Jamaica or Morocco?
- Morocco, at 1,213 deaths against 1,044 deaths in Jamaica as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Jamaica and Morocco?
- 169 deaths, with Morocco ahead.
- How many years of comparable data are there for Jamaica and Morocco?
- 33 years are reported by both, from 1990 to 2022.
- How do Jamaica and Morocco rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Jamaica ranks 72nd and Morocco ranks 70th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.